A pan-cancer analysis revealed the role of the SLC16 family in cancer

References

• Graham TA, Sottoriva A. Measuring cancer evolution from the genome. J Pathol. 2017;241(2):183–191.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• Jemal A, MM C, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–1907.
   PubMed Web of Science ®Google Scholar
• Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227–232.
   PubMed Web of Science ®Google Scholar
• Bhattacharya B, Mohd Omar MF, Soong R. The Warburg effect and drug resistance. Br J Pharmacol. 2016;173(6):970–979.
   PubMed Web of Science ®Google Scholar
• Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44(5):1499–1505.
   PubMed Web of Science ®Google Scholar
• Fu Y, Liu S, Yin S, et al. The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy. Oncotarget. 2017 [Published 2017 May 25];8(34):57813–57825.
   PubMedGoogle Scholar
• Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021;599(6):1745–1757.
   PubMed Web of Science ®Google Scholar
• Lin L, Yee SW, Kim RB, et al. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015;14(8):543–560.
   PubMed Web of Science ®Google Scholar
• Liu X. SLC Family Transporters. Adv Exp Med Biol. 2019;1141:101–202.
   PubMed Web of Science ®Google Scholar
• Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med. 2013;34(2–3):337–349.
   PubMed Web of Science ®Google Scholar
• Felmlee MA, Jones RS, Rodriguez-Cruz V, et al. (SLC16): function, Regulation, and Role in Health and Disease. Pharmacol Rev. 2020;72(2):466–485.
   PubMed Web of Science ®Google Scholar
• Halestrap AP, The MD. SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 2004;447(5):619–628.
   PubMed Web of Science ®Google Scholar
• Halestrap AP. Monocarboxylic acid transport. Compr Physiol. 2013;3(4):1611–1643.
   PubMed Web of Science ®Google Scholar
• AP H, Wilson MC. The monocarboxylate transporter family–role and regulation. IUBMB Life. 2012;64(2):109–119.
   PubMed Web of Science ®Google Scholar
• Gallagher-Colombo S, Maminishkis A, Tate S, et al. Modulation of MCT3 expression during wound healing of the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2010;51(10):5343–5350.
   PubMed Web of Science ®Google Scholar
• Sun S, Li H, Chen J, et al. No Longer an Inert and End-Product of Glycolysis. Physiology (Bethesda). 2017;32(6):453–463.
   PubMed Web of Science ®Google Scholar
• Wang N, Jiang X, Zhang S, et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell. 2021;184(2):370–383.e13.
   PubMed Web of Science ®Google Scholar
• Marquard J, Welters A, Buschmann T, et al. Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma. Diabetologia. 2013;56(1):31–35.
   PubMed Web of Science ®Google Scholar
• Nikooie R, Rajabi H, Gharakhanlu R, et al. Exercise-induced changes of MCT1 in cardiac and skeletal muscles of diabetic rats induced by high-fat diet and STZ. J Physiol Biochem. 2013;69(4):865–877.
   PubMed Web of Science ®Google Scholar
• Gill RK, Saksena S, Alrefai WA, et al. Expression and membrane localization of MCT isoforms along the length of the human intestine. Am J Physiol Cell Physiol. 2005;289(4):C846–C852.
   PubMed Web of Science ®Google Scholar
• Lin WR, Chiang JM, Lim SN, et al. Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas. EBioMedicine. 2019;44:334–345.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kohyama N, Kobayashi Y, et al. Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug Metab Dispos. 2005;33(12):1845–1851.
   PubMed Web of Science ®Google Scholar
• Hugo SE, Cruz-Garcia L, Karanth S, et al. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev. 2012;26(3):282–293.
   PubMed Web of Science ®Google Scholar
• Karanth S, Schlegel A. The Monocarboxylate Transporter SLC16A6 Regulates Adult Length in Zebrafish and Is Associated With Height in Humans. Front Physiol. 2019;9:1936.
   PubMed Web of Science ®Google Scholar
• Grijota-Martínez C, Bárez-López S, Gómez-Andrés D, et al. MCT8 Deficiency: the Road to Therapies for a Rare Disease. Front Neurosci. 2020;14:380.
   PubMed Web of Science ®Google Scholar
• van Mullem AA, ALM VG, Visser WE, et al. Effects of thyroid hormone transporters MCT8 and MCT10 on nuclear activity of T3. Mol Cell Endocrinol. 2016;437:252–260.
   PubMed Web of Science ®Google Scholar
• Uemura S, Mochizuki T, Kurosaka G, et al. Functional analysis of human aromatic amino acid transporter MCT10/TAT1 using the yeast Saccharomyces cerevisiae. Biochim Biophys Acta Biomembr. 2017;1859(10):2076–2085.
   PubMed Web of Science ®Google Scholar
• Pérez-Escuredo J, Van Hée VF, Sboarina M, et al. Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta. 2016;1863(10):2481–2497.
   PubMed Web of Science ®Google Scholar
• Rusu V, Hoch E, Mercader JM, et al. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. Cell. 2017;170(1):199–212.e20.
   PubMed Web of Science ®Google Scholar
• Castorino JJ, Gallagher-Colombo SM, Levin AV, et al. Juvenile cataract-associated mutation of solute carrier SLC16A12 impairs trafficking of the protein to the plasma membrane. Invest Ophthalmol Vis Sci. 2011;52(9):6774–6784.
   PubMed Web of Science ®Google Scholar
• McClintick JN, Tischfield JA, Deng L, et al. Ethanol activates immune response in lymphoblastoid cells. Alcohol. 2019;79:81–91.
   PubMed Web of Science ®Google Scholar
• Knöpfel T, Atanassoff A, Hernando N, et al. Renal localization and regulation by dietary phosphate of the MCT14 orphan transporter. PLoS One. 2017;12(6):e0177942.
   PubMed Web of Science ®Google Scholar
• Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61–68.
   PubMed Web of Science ®Google Scholar
• Martincorena I, Campbell PJ Somatic mutation in cancer and normal cells [published correction appears in Science. 2016 Mar 4;351(6277).
   Google Scholar
• Zugazagoitia J, Guedes C, Ponce S, et al. Challenges in Cancer Treatment. Clin Ther. 2016;38(7):1551–1566.
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–196.
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557–4566.
   PubMed Web of Science ®Google Scholar
• Soysal SD, Tzankov A, Muenst SE. Role of the Tumor Microenvironment in Breast Cancer. Pathobiology. 2015;82(3–4):142–152.
   PubMed Web of Science ®Google Scholar
• Jarosz-Biej M, Smolarczyk R, Cichoń T, et al. Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy. Int J Mol Sci. 2019;20(13):3212.
   PubMed Web of Science ®Google Scholar
• Icard P, Shulman S, Farhat D, et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1–11.
   PubMed Web of Science ®Google Scholar
• Watson MJ, Vignali PDA, Mullett SJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645–651.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhu Z, Cao Y, et al. Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma. Channels (Austin). 2021;15(1):483–495.
   PubMed Web of Science ®Google Scholar
• Sohrabi E, Moslemi M, Rezaie E, et al. The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer [published online ahead of print, 2021 Jun 7]. Genes Genomics. 2021; https://doi.org/10.1007/s13258-021-01116-w.
   Google Scholar
• Choi SH, Kim MY, Yoon YS, et al. Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A. Biochim Biophys Acta Gene Regul Mech. 2019;1862(8):771–785.
   PubMed Web of Science ®Google Scholar
• Drögemöller BI, Monzon JG, Bhavsar AP, et al. Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA Oncol. 2017;3(11):1558–1562.
   PubMed Web of Science ®Google Scholar
• Dai W, Liu H, Chen K, et al. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. Mol Carcinog. 2020;59(6):640–650.
   PubMed Web of Science ®Google Scholar
• Pertega-Gomes N, Vizcaino JR, Felisbino S, et al. Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer. Oncotarget. 2015;6(25):21675–21684.
   PubMedGoogle Scholar
• Lamb R, Harrison H, Hulit J, et al. Mitochondria as new therapeutic targets for eradicating cancer stem cells: quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 2014;5(22):11029–11037.
   PubMed Web of Science ®Google Scholar
• Mei J, Hu K, Peng X, et al. Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma. Medicine (Baltimore). 2019;98(30):e16624.
   PubMed Web of Science ®Google Scholar
• Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev. 2015;44(10):2963–2997.
   PubMed Web of Science ®Google Scholar
• Andor N, Maley CC, Ji HP. Genomic Instability in Cancer: teetering on the Limit of Tolerance. Cancer Res. 2017;77(9):2179–2185.
   PubMed Web of Science ®Google Scholar
• Tubbs A, Nussenzweig A. Endogenous DNA Damage as a Source of Genomic Instability in Cancer. Cell. 2017;168(4):644–656.
   PubMed Web of Science ®Google Scholar
• Vinay DS, Ryan EP, Pawelec G, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35(Suppl):S185–S198.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brahmer JR, Callahan MK, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6(1):38.
   PubMed Web of Science ®Google Scholar
• Fujii SI, Shimizu K. Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer. Trends Immunol. 2019;40(11):984–997.
   PubMed Web of Science ®Google Scholar
• Najafi M, Mortezaee K, Majidpoor J. Cancer stem cell (CSC) resistance drivers. Life Sci. 2019;234:116781.
   PubMed Web of Science ®Google Scholar